Navigation Links
U.S. Unveils Database of Genetic, Clinical Research
Date:10/14/2007

Goal is to advance understanding of ills such as heart disease

SUNDAY, Oct. 14 (HealthDay News) -- One of the largest collections of genetic and clinical data available free to researchers worldwide has been launched by the U.S. National Institutes of Health.

The Web-based SHARe (SNP Health Association Resource) dataset enables eligible researchers to access data from a number of large population-based studies, starting with the Framingham Heart Study, which includes data on thousands of residents of Framingham, Mass., spanning three generations. The participants in that study had their DNA tested for 550,000 genetic variations.

The goal of SHARe is to speed discoveries linking genes and health and improve understanding of the causes of, and prevention of, a number of different kinds of diseases.

"SHARe represents a major milestone in moving toward an era of personalized health care -- a future in which the ways we prevent, diagnose and treat health problems are tailored to an individual's genetic makeup," U.S. Health and Human Services Secretary Mike Leavitt said in a prepared statement.

SHARe is accessed through the database of Genotypes and Phenotypes (dbGaP), a Web-based resource for archiving and distributing data from genome-wide association studies that examine the associations between genes and traits such as weight, cholesterol levels, or the presence/absence of disease. Launched in 2006, dbGaP is operated by the National Center for Biotechnology Information, a division of the U.S. National Library of Medicine (NLM).

"The SHARe data offer an unparalleled level of study detail, providing a wealth of opportunities for researchers, students and others to learn about study design from some of the brightest minds working in the field," NLM Director Dr. Donald A.B. Lindberg said in a prepared statement.

More information

The U.S. National Library of Medicine has more about genes and health.



-- Robert Preidt



SOURCE: U.S. National Institutes of Health, news release, October 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. Study Unveils New Insight To The Madness Of King George III
3. Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic
4. Rae unveils Health-care Strategy
5. Study Unveils West Nile Virus Immune Evasion, Points to Vaccine Development
6. Pesticides Linked to High Risk of Pediatric Cancers - a Study Unveils
7. Pet Owners Less Healthy: Study Unveils
8. Biocon Unveils Renal Therapies for Kidney Disorders
9. China Unveils Green Plan to Revert Farmland to Forest
10. Japanese Firm Unveils Artificial Hand With air Muscles
11. Boeing Unveils green Dreamliner Passenger Jet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: